Free Trial

Taylor Frigon Capital Management LLC Sells 1,948 Shares of Astera Labs, Inc. $ALAB

Astera Labs logo with Computer and Technology background

Key Points

  • Taylor Frigon Capital Management LLC reduced its holdings in Astera Labs by 6.2%, owning 29,679 shares valued at $2.68 million after selling 1,948 shares in the 2nd quarter.
  • Several institutional investors showed increased interest in Astera Labs, with notable acquisitions and increases in holdings reported, indicating a 60.47% ownership among hedge funds and institutional investors.
  • Astera Labs reported a net margin of 16.54% and a quarterly revenue increase of 149.5% year-over-year, exceeding consensus estimates and showcasing strong growth potential.
  • MarketBeat previews top five stocks to own in October.

Taylor Frigon Capital Management LLC trimmed its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 6.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 29,679 shares of the company's stock after selling 1,948 shares during the period. Astera Labs makes up approximately 1.4% of Taylor Frigon Capital Management LLC's holdings, making the stock its 18th largest position. Taylor Frigon Capital Management LLC's holdings in Astera Labs were worth $2,684,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Oliver Lagore Vanvalin Investment Group bought a new stake in shares of Astera Labs in the 2nd quarter worth $29,000. GAMMA Investing LLC raised its holdings in Astera Labs by 55.7% in the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after purchasing an additional 284 shares during the period. Sound Income Strategies LLC raised its stake in shares of Astera Labs by 34.7% in the first quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after buying an additional 204 shares during the period. Harbour Investments Inc. lifted its holdings in Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock valued at $47,000 after purchasing an additional 619 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new position in Astera Labs in the 1st quarter worth $48,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the transaction, the director directly owned 385,863 shares in the company, valued at $66,858,482.01. The trade was a 32.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Michael Truett Tate sold 100,000 shares of the stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $171.38, for a total value of $17,138,000.00. Following the sale, the chief financial officer directly owned 518,996 shares in the company, valued at $88,945,534.48. This represents a 16.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 1,576,027 shares of company stock worth $239,177,011. 12.50% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several analysts have commented on ALAB shares. Barclays reiterated an "overweight" rating and issued a $155.00 price target (up previously from $75.00) on shares of Astera Labs in a research note on Thursday, August 7th. Needham & Company LLC increased their target price on shares of Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Susquehanna boosted their price objective on Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a report on Thursday, August 7th. CICC Research began coverage on shares of Astera Labs in a research note on Friday, August 29th. They issued an "outperform" rating and a $190.00 target price on the stock. Finally, Citigroup raised their price target on Astera Labs from $160.00 to $275.00 and gave the company a "buy" rating in a research note on Wednesday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $152.94.

Get Our Latest Stock Analysis on ALAB

Astera Labs Stock Performance

Shares of ALAB stock opened at $197.78 on Monday. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The firm has a market capitalization of $32.87 billion, a PE ratio of 353.18, a P/E/G ratio of 5.02 and a beta of 1.46. The stock's 50-day simple moving average is $181.88 and its 200-day simple moving average is $115.31.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. During the same quarter in the prior year, the company earned $0.13 EPS. Astera Labs's quarterly revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Sell-side analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Astera Labs Company Profile

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Articles

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.